- Home
- TSBK vs ADAP Comparison
TSBK vs ADAP Comparison
Compare TSBK & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSBK
- ADAP
- Stock Information
- Founded
- TSBK 1915
- ADAP 2008
- Country
- TSBK United States
- ADAP United Kingdom
- Employees
- TSBK N/A
- ADAP N/A
- Industry
- TSBK Banks
- ADAP Biotechnology: Pharmaceutical Preparations
- Sector
- TSBK Finance
- ADAP Health Care
- Exchange
- TSBK Nasdaq
- ADAP Nasdaq
- Market Cap
- TSBK 260.4M
- ADAP 212.3M
- IPO Year
- TSBK 1998
- ADAP 2015
- Fundamental
- Price
- TSBK $33.00
- ADAP $0.60
- Analyst Decision
- TSBK
- ADAP Strong Buy
- Analyst Count
- TSBK 0
- ADAP 4
- Target Price
- TSBK N/A
- ADAP $2.79
- AVG Volume (30 Days)
- TSBK 11.6K
- ADAP 2.1M
- Earning Date
- TSBK 01-21-2025
- ADAP 11-13-2024
- Dividend Yield
- TSBK 3.08%
- ADAP N/A
- EPS Growth
- TSBK N/A
- ADAP N/A
- EPS
- TSBK 3.01
- ADAP N/A
- Revenue
- TSBK $74,154,000.00
- ADAP $175,041,000.00
- Revenue This Year
- TSBK N/A
- ADAP $204.91
- Revenue Next Year
- TSBK N/A
- ADAP N/A
- P/E Ratio
- TSBK $10.88
- ADAP N/A
- Revenue Growth
- TSBK N/A
- ADAP 146.27
- 52 Week Low
- TSBK $23.93
- ADAP $0.43
- 52 Week High
- TSBK $33.98
- ADAP $2.05
- Technical
- Relative Strength Index (RSI)
- TSBK 51.81
- ADAP 37.29
- Support Level
- TSBK $32.40
- ADAP $0.57
- Resistance Level
- TSBK $32.95
- ADAP $0.61
- Average True Range (ATR)
- TSBK 0.59
- ADAP 0.04
- MACD
- TSBK -0.13
- ADAP -0.00
- Stochastic Oscillator
- TSBK 34.06
- ADAP 27.46
About TSBK Timberland Bancorp Inc.
Timberland Bancorp Inc is a bank holding company. The bank offers a variety of services such as checking accounts, online and mobile banking, savings accounts, home loans, consumer loans, construction loans, business rewards, cash management, small business solutions, and business checking accounts among others. Company also offers loans to real estate, including residential and commercial / multi-family construction loans, one- to four-family residential loans, multi-family loans, commercial real estate loans and land loans. The company mainly operates in the United States.
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.